Company Filing History:
5 out of 3,923 
5 out of 2,597 
Years Active: 2017-2025
Title: Innovations of Julia Jascur in Cancer Treatment
Introduction
Julia Jascur, an accomplished inventor based in Basel, Switzerland, has made significant contributions to the field of cancer treatment through her innovative work. With a total of five patents to her name, she has been pivotal in advancing therapeutic techniques targeting specific tumor antigens.
Latest Patents
Among her latest patents is a groundbreaking invention titled "Treatment of cancer using a CD33 chimeric antigen receptor." This innovation provides compositions and methods for treating diseases associated with the expression of CD33. The invention relates to a chimeric antigen receptor (CAR) specific to CD33, as well as vectors encoding the receptor and recombinant T cells that express the CD33 CAR. Additionally, the patent includes methods for administering genetically modified T cells that express a CAR with a CD33 binding domain.
Another notable patent is related to "Phosphoglycerate kinase 1 (PGK) promoters and methods of use for expressing chimeric antigen receptor." This invention offers compositions and methods for treating conditions linked to tumor antigens. It encompasses nucleic acids with truncated PGK promoters operably linked to CARs specific to tumor antigens, as well as vectors and recombinant T cells incorporating these CARs. The invention also contains protocols for administering genetically modified T cells that express a CAR with an antigen binding domain that targets specific tumor antigens.
Career Highlights
Julia has an impressive professional background, having worked with renowned organizations such as Novartis AG and the University of Pennsylvania. Her experiences at these institutions have been instrumental in shaping her research and fostering her innovative spirit.
Collaborations
In her career, Julia has collaborated with several esteemed colleagues, including Hilmar Erhard Ebersbach and Qilong Wu. These partnerships have allowed for the exchange of ideas and expertise, driving forward the potential applications of her inventions in the field of oncology.
Conclusion
Julia Jascur stands out as a leading innovator in cancer treatment, with her patents paving the way for the development of targeted therapies using chimeric antigen receptors. Her work embodies the spirit of innovation, showcasing how scientific advancements can impact the medical field and offer hope to patients battling cancer.